What happened

Saba Capital Management, L.P. bought 72,720 common shares of Highland Opportunities & Income Fund (NYSE: HFRO) on Nov. 19. The purchase added to an established stake held by an investor the filing identifies as a 10% owner.

The buyer paid about $375,000 at $5.16 per share. The trade brought its beneficial holding to 6,318,497 shares.

Why it matters

The purchase was small relative to the buyer’s existing position. OptimistFi calculates that it increased the buyer’s share count by 1.2% from 6,245,777 shares immediately before the trade.

The purchase was in common stock, so the comparison tracks the same class of shares before and after the trade. The percentage measures growth in the buyer’s position rather than the portion of the fund the buyer acquired.

The two dollar figures describe the same transaction at different scales. The price applies to each share in the purchase, while the total covers the block that changed hands. The resulting share balance includes the shares already held before the trade.

The ownership is indirect: the shares are held by funds or accounts the buyer manages. The new balance gives investors a benchmark for tracking that position, but the increase reflects a single purchase.

Saba Capital Management, L.P. reported the purchase as the sole reporting owner. Saba Capital Management GP, LLC is its general partner. The filing identifies Boaz R. Weinstein as the managing member of that general partner, distinct from the investment manager named as the reporting owner.

The signatures are dated Nov. 20, but the transaction date anchors the change in ownership. The reported balance is the position immediately after the purchase. For any later comparison, the matching figure is the same investment manager’s beneficial common-share count.

The filing records the shares as acquired and lists the purchase price alongside the resulting indirect holding.

What's next

At the next quarterly report, any update on the holding can be measured against the post-purchase balance.

Sources checked automatically Nov 21, 2026 · Human review: none
Thesis impactHFRO: no published thesis yet.